Head Office and Cluster Reports
總辦事處及醫院聯網工作匯報
52
Hospital Authority Annual Report 2013-2014
New software was developed for Unique Patient Identification
devices to enhance safety of blood administration procedures
by meeting the International Society of Blood Transfusion global
standard (ISBT 128) for identification, labelling and information
transfer of human blood.
The new In-patient Medication Order Entry system implemented
in Princess Margaret Hospital enhanced clinical workflow efficiency
and reduced potential medication prescription errors. The next
phase of Clinical Management System has commenced to enhance
clinical communications and workflow.
HA adopts modern technology and new treatment options to
enhance quality and safety. The scope of HA Drug Formulary was
widened in the second quarter of 2013 to cover more drugs with
accumulated scientific evidence on clinical efficacy. Two self-
financed cancer drugs were repositioned as Special Drugs in the
HA Drug Formulary for treatment of head and neck cancer as well
as malignant pleural mesothelioma. The clinical applications of
two therapeutic groups of drugs were expanded for treatment of
colorectal cancer and advanced Parkinson’s disease.
我們研發了一個配合「國際輸血學會」核准編碼標
準
(ISBT 128)
的軟件程式，用於人類血液的識別、
標示及資訊傳輸。此程式應用於病人身份確認系
統，加強血液管理程序安全。
於瑪嘉烈醫院實施的住院病人藥物指令輸入系
統，有助提升臨床工作效率，並減少藥物處方出錯
的潛在風險。臨床管理系統下一階段的工作亦已展
開，以優化臨床資訊互通及工作流程。
醫管局採用先進技術及嶄新療法，提升質素及安
全。醫管局藥物名冊在
2013
年第二季擴大涵蓋範
圍，納入更多已累積臨床效益實證的藥物。兩種自
費癌症藥物改列作專用藥物，治療頭頸癌及惡性肋
膜間質細胞瘤，另擴大兩類治療組別藥物的臨床應
用範圍，用以治療大腸癌及晚期柏金遜症病人。
